India Drug Healthcare

top of page

AstraZeneca's trastuzumab deruxtecan approved by CDSCO for adults with HER2-positive Stage II or III early breast cancer | iPharmaCenter

Badari Andukuri

Jul 30

India's CDSCO Grants Regulatory Approval for Takeda’s Qdenga Dengue Vaccine

Badari Andukuri

Jul 21

CDSCO Approves AstraZeneca's Enhertu as New First-Line Combination for HER2-Positive Breast Cancer in India

Badari Andukuri

Jun 24

AstraZeneca Introduces K+ Connect Program Across India for Hyperkalemia Management

AstraZeneca Introduces K+ Connect Program Across India for Hyperkalemia Management

AstraZeneca Introduces K+ Connect Program Across India for Hyperkalemia Management

Badari Andukuri

May 15

CDSCO Clears Durvalumab with FLOT as New Perioperative Standard for Gastric Cancer Patients in India | iPharmaCenter

CDSCO Clears Durvalumab with FLOT as New Perioperative Standard for Gastric Cancer Patients in India | iPharmaCenter

CDSCO Clears Durvalumab with FLOT as New Perioperative Standard for Gastric Cancer Patients in India | iPharmaCenter

ipharmaservices

Feb 2

Sun Pharma obtains DCGI nod to produce generic semaglutide injection for weight management in India | iPharmaCenter

Badari Andukuri

Jan 25

Sun Pharma Launches ILUMYA in India for Psoriasis Patients | iPharmaCenter

Badari Andukuri

Dec 4, 2025

AstraZeneca Secures CDSCO Approval for Durvalumab in Limited-Stage Small Cell Lung Cancer Treatment | iPharmaCenter

ipharmaservices

Mar 11, 2025

Dr. Reddy’s Launches Toripalimab in India for Nasopharyngeal Carcinoma Treatment | iPharmaCenter

ipharmaservices

Dec 27, 2024

Sanofi Secures Approval for Beyfortus in India to Shield Infants and Children from RSV | iPharmaCenter

Sanofi Secures Approval for Beyfortus in India to Shield Infants and Children from RSV | iPharmaCenter

Sanofi Secures Approval for Beyfortus in India to Shield Infants and Children from RSV | iPharmaCenter

ipharmaservices

Aug 6, 2024

Indian Pharma News | 2024 | iPharmaCenter

Indian Pharma News | 2024 | iPharmaCenter

Indian Pharma News | 2024 | iPharmaCenter

ipharmaservices

May 23, 2024

India Drug Approvals | 2024 | CDSCO | News | Updates | Media | iPharmaCenter

India Drug Approvals | 2024 | CDSCO | News | Updates | Media | iPharmaCenter

India Drug Approvals | 2024 | CDSCO | News | Updates | Media | iPharmaCenter

ipharmaservices

May 13, 2024

India | Drug Approvals | Pharma News | 2024 | iPharmaCenter

India | Drug Approvals | Pharma News | 2024 | iPharmaCenter

India | Drug Approvals | Pharma News | 2024 | iPharmaCenter

ipharmaservices

Jan 6, 2024

India new drug approvals | India Pharma | 2023 | CDSCO | Ministry of health news | iPharmaCenter

India new drug approvals | India Pharma | 2023 | CDSCO | Ministry of health news | iPharmaCenter

India new drug approvals | India Pharma | 2023 | CDSCO | Ministry of health news | iPharmaCenter

ipharmaservices

Oct 10, 2023

India | Healthcare News | Abbott to upgrade 75 PHCs | iPharmaCenter

India | Healthcare News | Abbott to upgrade 75 PHCs | iPharmaCenter

India | Healthcare News | Abbott to upgrade 75 PHCs | iPharmaCenter

ipharmaservices

Sep 30, 2023

Department of Pharmaceuticals report emphasize on need of academia to meet industry's requirement

Department of Pharmaceuticals report emphasize on need of academia to meet industry's requirement

Department of Pharmaceuticals report emphasize on need of academia to meet industry's requirement

ipharmaservices

Aug 12, 2023

bottom of page